ABSTRACT OBJECTIVES This study sought to investigate the role of carotid fluoro-2-deoxyglucose (FDG) uptake as an independent prognostic indicator and to determine whether its addition improves risk prediction beyond the Framingham risk score (FRS) and carotid intima-media thickness (CIMT).
I
nflammation plays a key role in atherosclerosis progression and triggers plaque instability (1-3), the major pathophysiology underlying myocardial infarction and stroke (4, 5) . Accordingly, there is accumulating evidence suggesting the usefulness of inflammatory biomarkers for predicting cardiocerebrovascular events (6) (7) (8) (9) . For example, serum highsensitivity C-reactive protein (hsCRP) has been shown to correlate with traditional risk factors (9) and predict cardiovascular risk in apparently healthy adults (6, 7) and unstable angina patients (8) . Fluorine 18-fluoro-2-deoxyglucose (FDG) positron emission tomography (PET) is a noninvasive imaging study widely used for cancer. Because activated macrophages avidly take up FDG, PET can also detect inflammatory lesions with high sensitivity, with uptake magnitude as an indicator of inflammation severity (10) (11) (12) (13) . This has led to an increasing interest in the use of FDG PET in atherosclerosis, and many studies point to a positive correlation between arterial uptake and traditional cardiac risk factors (14, 15) . There have been a few recent attempts to evaluate an association between arterial FDG uptake and subject outcome (16) (17) (18) . However, these studies were limited by a small number of subjects, underlying cancer disease, short follow-up, and failure to compare with traditional risk factors (16, 17) . In a more recent study, Fig The precise prognostic value of carotid FDG uptake for future cardiovascular events, therefore, remains to be explored.
In this study, we evaluated a large cohort of asymptomatic adults to investigate the role of carotid FDG uptake as an independent prognostic indicator and to determine whether its addition improves risk prediction beyond the Framingham risk score (FRS) and carotid intima-media thickness (CIMT). were selected. Among these, 16 subjects were excluded because of pre-existing coronary heart disease (n ¼ 4) and stroke (n ¼ 12); 29 subjects were excluded for lack of PET/CT data (n ¼ 14), inaccessible electronic medical records (n ¼ 1), or carotid uptake obscured by adjacent tissue (n ¼ 14). Additionally, 92 subjects were excluded because of being lost to follow-up (n ¼ 61) or follow-up was <1 year (n ¼ 31). Thus, 1,089 subjects were finally included.
None of the subjects had cardiac or neurological symptoms at the time of PET/CT. The institutional review board approved this retrospective cohort study, and the requirement to obtain informed consent was waived.
MEASUREMENT OF CIMT. CIMT was measured by experienced radiologists using Vivid (GE Vingmed PET/CT IMAGING. All subjects were instructed to fast for at least 6 h before the PET/CT study, and blood glucose levels were <200 mg/dl at the time of FDG injection. Imaging was performed in the majority of the subjects (n ¼ 1,082) using a GE Healthcare STE scanner (Wauwatosa, Wisconsin), whereas a GE Discovery LS scanner was used in 7 subjects. At 45 min after injection of 370 MBq FDG, CT images were ac- (median 9.8%; interquartile range: 6.5% to 14.7%).
When we compared this study population (subjects who had CIMT measurements; n ¼ 1,089) with subjects who did not have CIMT measurements (n ¼ 1,103), a higher male preponderance and younger age was noted for the former group. Importantly, however, there was no difference in the FRS between the 2 groups, and this remained true when only male subjects were analyzed (data not shown).
On average, participants had a carotid M-TBR of Values are mean AE SD, n (%), or mean AE SD (median, interquartile range).
BP ¼ blood pressure; CIMT ¼ carotid intima-media thickness; FDG ¼ fluoro-2-deoxyglucose; FPG ¼ fasting plasma glucose; GFR ¼ glomerular filtration rate; HDL-C ¼ high-density lipoprotein cholesterol; hsCRP ¼ high sensitive C-reactive protein; LDL-C ¼ low-density lipoprotein cholesterol; M-TBR ¼ maximal target-to-blood pool ratio; SUVmax ¼ maximal standard uptake value.
Carotid FDG Uptake Predicts Events significantly higher FRS (13.9 AE 9.9% vs. 11.4 AE 7%; p < 0.000) and higher incidence of cardiocerebrovascular events (3.3% vs. 1.0%; p ¼ 0.011) compared with the low FDG uptake group (Figure 1) .
The difference in cardiocerebrovascular event rate between the 2 groups was significant in the high CIMT category, whereas it did not reach statistical significance in the low CIMT category (Figure 2) . Table 1 Table 1 ). All 8 patients in whom angina developed also underwent coronary angiography (Online Table 1 Comparison of cumulative event-free survival rates between groups stratified by carotid FDG uptake (A) and carotid intima-media thickness (B). Differences between groups were analyzed by log-rank tests. CIMT ¼ carotid intima-media thickness; FDG ¼ fluoro-2-deoxyglucose.
CARDIOCEREBROVASCULAR EVENTS AND COX
REGRESSION. Over a mean follow-up period of 4.2 AE 1.0 years (range 1 to 5.5 years), 19 of 1,089 subjects (1.74%) experienced cardiocerebrovascular events (Online
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A U G U S T 2 0 1 5 : 9 4 9 -5 6 uptake died during follow-up. However, this was not included as a vascular event because the cause of death was unknown. When subjects with events were divided according to FDG uptake, there was no difference in demographic and clinical characteristics (Online Table 2 ).
On univariate analysis, Cox regression demonstrated a significant association of high CIMT, high hsCRP, and high FDG uptake with increased cardiocerebrovascular events ( Table 2 ). Table 2) . Table 3) . IDI results for adding carotid FDG uptake to models including the FRS, CIMT, and hsCRP are also shown in Table 3 . 
1.7
Event rates between high and low FDG uptake groups were significantly different in the high CIMT category (p ¼ 0.047), whereas it did not reach statistical significance in the low CIMT category (p ¼ 0.116). Abbreviations as in Figure 1 .
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Carotid FDG Uptake Predicts Events FDG PET. Furthermore, it was previously shown that hsCRP and carotid FDG uptake provide distinct prognostic information (19) . Our NRI results showed that 40.1% and 32.9% more subjects were appropriately reclassified than 
